Author:
Aghai-Trommeschlaeger Fatemeh,Zimmermann Sebastian,Gesierich Anja,Kalogirou Charis,Goebeler Maria-Elisabeth,Jung Pius,Pelzer Theo,Kurlbaum Max,Klinker Hartwig,Isberner Nora,Scherf-Clavel Oliver
Subject
Clinical Biochemistry,General Medicine
Reference47 articles.
1. Kinases as targets in the treatment of solid tumors;Giamas;Cell Signal,2010
2. Therapeutic Drug Monitoring of Targeted Anticancer Protein Kinase Inhibitors in Routine Clinical Use: A Critical Review;Cardoso;Ther. Drug Monit.,2020
3. Utility of therapeutic drug monitoring of imatinib, nilotinib, and dasatinib in chronic myeloid leukemia: a systematic review and meta-analysis;Garcia-Ferrer;Clin. Ther.,2019
4. Pharmacokinetic Targets for Therapeutic Drug Monitoring of Small Molecule Kinase Inhibitors in Pediatric Oncology;Janssen;Clin. Pharmacol. Ther.,2020
5. FDA- and EMA-approved tyrosine kinase inhibitors in advanced egfr-mutated non-small cell lung cancer: safety, tolerability;Solassol;Plasma Concentration Monitoring, and Management, Biomolecules,2019
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献